MedTrace Logo

Preliminary Tissue Monitoring During Endovascular Intervention Study

NCT04956523 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 20

Last updated 2021-07-09

No results posted yet for this study

Summary

Tissue perfusion assessment is key to more accurate measurement of foot ischemia, which is in turn an important factor in appropriate treatment decisions. In practice though, tissue perfusion measurements are not routinely undertaken as few practical solutions exist that are easy to use and fit in everyday clinical practice. Pedra has developed a novel easy to use, non-invasive device that can be used in practice to better inform treatment decisions.

Conditions

Sponsors & Collaborators

  • Pedra Technology, PTE LTD

    lead INDUSTRY

Eligibility

Min Age
40 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-10-01
Primary Completion
2021-12-01
Completion
2022-03-01

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04956523 on ClinicalTrials.gov